Receiving dialysis while enrolled in hospice is technically possible but practically difficult under traditional Medicare, which is the insurer most people on hospice use. The standard Medicare hospice benefit requires patients to choose comfort-focused care and forgo treatments considered curative or life-prolonging for their terminal diagnosis. Because dialysis for end-stage kidney disease falls squarely into that category, most patients face a stark either-or choice. The reality, though, is more layered than that simple rule suggests, and the landscape is slowly shifting.
Why Medicare Creates an Either-Or Choice
Under the Medicare hospice benefit, a patient who enrolls agrees to receive comfort care for their terminal illness in exchange for a daily payment that covers medications, nursing visits, counseling, and other hospice services. The hospice agency receives a flat per-diem rate from Medicare to cover all costs related to the terminal diagnosis. Outpatient hemodialysis, which can run several hundred dollars per session three times a week, would blow through that per-diem budget almost immediately. Most hospice agencies simply cannot absorb that cost, and Medicare does not pay for it separately once hospice is elected.
This structural problem means that for most people with end-stage kidney disease, enrolling in hospice has effectively meant stopping dialysis. A commentary in JAMA Internal Medicine argued that this forced linkage between hospice enrollment and dialysis discontinuation is a policy failure, not a medical inevitability, and called for breaking that connection so patients could access the comfort-focused services of hospice without being required to give up a treatment that manages severe symptoms like fluid overload and uremia.
What Palliative Dialysis Actually Looks Like
Not all dialysis is aimed at keeping someone alive as long as possible. Palliative dialysis is a concept that has gained traction among kidney specialists over the past decade. The idea is that for patients with a life expectancy under a year, dialysis can be restructured around quality of life rather than lab values or longevity targets. That might mean fewer sessions per week, shorter treatment times, or choosing peritoneal dialysis at home over in-center hemodialysis, all with the goal of managing distressing symptoms while reducing the burden of treatment.
A framework published in the Clinical Journal of the American Society of Nephrology describes this approach as aligning treatment with patients’ informed preferences, recognizing that many dialysis patients nearing the end of life may want symptom relief without the full intensity of a standard dialysis schedule.1PubMed Central. A palliative approach to dialysis care: a patient-centered transition to the end of life A more recent paper in the American Journal of Kidney Diseases makes the case that the current dialysis model is largely disease-focused, designed to preserve longevity and minimize complications, often with transplantation as the goal. For patients living with high rates of frailty and multiple other serious illnesses, those goals may not be realistic or even desired.2PubMed. Palliative Dialysis: Putting the Person First in Dialysis Care
Palliative dialysis is not a formal insurance category. There is no billing code for it. It exists as a clinical philosophy that individual nephrologists can adopt, reducing the dose or frequency of dialysis to what the patient actually needs for comfort. Some nephrology textbooks recommend considering it for patients who have a life expectancy under one year, symptoms that dialysis could still relieve, and values that make a trial of continued treatment reasonable.3Palliative Care in Nephrology. Palliative Dialysis The challenge is that without a reimbursement pathway that connects palliative dialysis to hospice enrollment, patients and families are left navigating a gap between what makes medical sense and what the insurance system will pay for.
Veterans Get a Different Deal
The Veterans Affairs health system operates its own hospice programs and is not bound by the same payment structure as Medicare’s hospice benefit. This creates a natural experiment in what happens when the financial barrier is removed. A study of US veterans with end-stage kidney disease found that among those receiving VA-financed hospice through community care contracts, about 42% received concurrent dialysis and hospice services. For veterans in VA inpatient hospice, the figure was closer to 55%. Compare that with veterans whose hospice was financed through traditional Medicare: only about 25% received concurrent care.4JAMA Health Forum. Association of Hospice Payer With Concurrent Receipt of Hospice and Dialysis Among US Veterans With End-stage Kidney Disease
The gap is striking and it is not driven by differences in how sick the patients were. It reflects the payer structure. When the system paying for hospice can also absorb or separately fund dialysis costs, patients are far more likely to receive both. The VA model is the strongest evidence that concurrent dialysis and hospice is feasible when the payment rules allow it.
What Happens When Dialysis Stops
For patients who do stop dialysis and enroll in hospice, the timeline is usually short. A study of nearly 2,000 patients who discontinued dialysis found that mean survival after hospice enrollment was just 7.4 days, with a range of zero to 40 days. That is dramatically shorter than the experience of other hospice patients: those with nonrenal terminal diagnoses survived an average of 54 days after hospice enrollment.5PubMed Central. Survival after dialysis discontinuation and hospice enrollment for ESRD Factors associated with dying sooner included being male, being referred from a hospital rather than an outpatient setting, having lower functional status, and having peripheral edema at the time of enrollment.
A separate study looking specifically at survival from the last dialysis session to death found a median of six days for hemodialysis patients and four days for peritoneal dialysis patients, with no meaningful difference between the two.6Kidney International Reports. Prognostication After Dialysis Withdrawal Patients who stopped dialysis for psychosocial reasons (burnout, quality-of-life concerns, or personal choice) tended to survive longer than those who stopped because of acute medical deterioration, which makes intuitive sense: someone stopping by choice is likely in somewhat better shape than someone whose body is already shutting down.
The practical implication is sobering. If a patient stops dialysis and then enrolls in hospice, there is often barely enough time for hospice services to ramp up. Hospice teams need at least a few days to assess the home environment, coordinate medications, and support the family. A week of hospice care after years of dialysis barely scratches the surface of what comfort-focused end-of-life care can offer.
Hospice Eligibility Guidelines Are Poorly Calibrated for Kidney Disease
Part of why patients with end-stage kidney disease get so little time on hospice is that the criteria used to determine when they qualify are unreliable. Medicare uses Local Coverage Determination guidelines to establish whether a patient has a life expectancy of six months or less, which is the threshold for hospice eligibility. For kidney disease, these guidelines include measures like declining kidney function, poor nutritional status, and clinical complications.
A study evaluating how well these guidelines actually predicted six-month survival found they were remarkably poor. Among patients who had died and who met the LCD criteria for kidney disease at the time of death, only 28% had met those criteria at least one month before dying. Just 5% had met them six months prior, which is supposedly what the guidelines are designed to identify. The median time a patient met the criteria before death was nine days.7PubMed. Accuracy of Medicare Hospice Local Coverage Determination Guidelines for End-Stage Kidney Disease
Nine days. That means the guidelines designed to identify people with six months to live are, in practice, identifying people with about a week. This is a major reason kidney disease patients enter hospice so late and get so few of its benefits. The eligibility criteria are essentially broken for this population, and fixing them could make a meaningful difference in how many patients get timely access to comfort care, whether or not they continue dialysis.
When Hospice Enrollment Is Too Short to Help
Late hospice enrollment is not just a paperwork problem. It directly affects the quality of care people receive in their final weeks. Research on hemodialysis patients found that those who had more than three days of hospice care before dying had fewer invasive procedures, fewer hospital admissions, and fewer ICU stays in their last month of life compared with patients who never enrolled in hospice at all. But patients with three or fewer days of hospice care actually had higher rates of hospitalization and ICU admission than patients with no hospice whatsoever.8American Journal of Kidney Diseases. Hospice Among Hemodialysis Patients: Too Little, Too Late to Impact Care Delivery or Costs?
That last finding is counterintuitive until you think about what it represents. Patients who enroll in hospice in the final day or two of life are typically in crisis. They are being transitioned to comfort care in the middle of a hospital stay, after aggressive interventions have already been tried. The hospice enrollment is less a proactive choice and more a recognition that everything else has failed. It offers almost none of the benefits that earlier enrollment provides: symptom management at home, emotional support for the family, coordinated medication adjustments, and time to grieve and prepare.
Conservative Kidney Management as an Alternative Path
Some patients with advanced kidney disease decide not to start dialysis at all, choosing instead what is now called conservative kidney management. This approach focuses on slowing kidney decline through diet, medications, and symptom control, without the physical and time demands of regular dialysis sessions. It is not the same as doing nothing; it is an active treatment plan that prioritizes comfort and autonomy.
A meta-analysis of 12 studies comparing patients who chose dialysis with those who chose conservative care found that dialysis was associated with longer survival overall, with a median survival advantage of about 22 months. But that advantage shrank substantially for older patients and those with severe comorbidities.9PubMed Central. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis A more recent review found that conservative management provided comparable or even better health-related quality of life than dialysis in older adults, was associated with fewer hospitalizations, and resulted in more patients dying at home, which many people prefer.10PubMed Central. Dialysis versus conservative kidney management in older adults: why one size does not fit all
For someone considering hospice, conservative kidney management may be a more natural fit than the abrupt switch from three-times-weekly dialysis to no dialysis at all. It offers a middle ground, and because the patient is not receiving dialysis, the financial conflict with the Medicare hospice benefit disappears. The tradeoff is a shorter expected lifespan for most patients, though for the frailest and oldest, that difference may be negligible.
Family Dynamics in the Decision
Decisions about stopping or continuing dialysis rarely happen in isolation. A qualitative study of nephrologists in the US and England explored how families influence these choices and found that family involvement can cut both ways. Sometimes families facilitate the transition by accepting the patient’s wishes and supporting a shift to comfort care. Other times, families act as barriers, driven by emotional responses to the idea of stopping treatment, distrust of physicians, or difficulty accepting that continued dialysis is not helping.
US nephrologists raised a factor that their English counterparts did not: families’ financial dependence on patients as a reason to resist stopping dialysis.11PubMed Central. Family Involvement in Decisions to Forego or Withdraw Dialysis In the American healthcare system, a patient’s survival can be tied to a family’s insurance coverage, housing stability, or income. That financial reality can make it harder for families to accept a transition to hospice even when the patient is suffering and has expressed a desire to stop treatment. The emotional weight of these decisions is enormous, and it is compounded when the system forces patients to choose between dialysis and hospice rather than offering both.
Advance Directives and Cognitive Decline
Many dialysis patients are older adults who may develop cognitive impairment over time. This raises a thorny problem: what happens when a patient wrote an advance directive years ago requesting that dialysis be stopped if they could no longer make decisions for themselves, but they now seem comfortable and unaware of their earlier wishes? Clinicians and families face a genuine ethical conflict between honoring the person’s previously stated autonomy and the instinct to continue treatment that appears to be sustaining someone who is not visibly suffering.12Journal of Dementia and Alzheimer’s Disease. Dilemmas in Implementing Advance Directives of Patients with Advanced Dementia
This is not a situation with a clean answer. Legally, advance directives are binding in most jurisdictions. Practically, the people responsible for carrying them out often hesitate. For dialysis patients specifically, the stakes are immediate: stopping dialysis leads to death within days, not weeks or months. That compressed timeline makes the decision feel more acute than, say, withdrawing a feeding tube, even though the ethical principles are similar. Having detailed, specific advance directives that address dialysis by name, along with ongoing conversations with family members and the medical team, gives everyone the best chance of honoring what the patient actually wanted.
Peritoneal Dialysis and Home-Based Options
When concurrent dialysis and hospice care is possible, the type of dialysis matters. In-center hemodialysis requires traveling to a clinic three times a week, sitting in a chair for several hours while connected to a machine, and dealing with the physical toll of rapid fluid removal. For someone enrolled in hospice, those trips are a significant burden and may directly conflict with the goal of spending remaining time at home with family.
Peritoneal dialysis, which uses the lining of the abdomen to filter waste and is typically done at home, fits more naturally with a hospice-at-home model. The patient or a caregiver manages the exchanges, and the treatment can be adjusted to prioritize comfort. Guidance on caring for older peritoneal dialysis patients at end of life emphasizes adapting the dialysis regimen to what the patient can tolerate, discussing goals of care including possible withdrawal, and providing psychosocial support alongside symptom management.13PubMed Central. Caring for Older Patients on Peritoneal Dialysis at End of Life However, caregiver burden is a real concern. Hemodialysis patients and their caregivers tend to experience higher rates of depression and caregiver strain compared to those on peritoneal dialysis, but peritoneal dialysis still requires active, daily involvement from someone in the household.14Oxford Academic (Nephrology Dialysis Transplantation). Depressive Burden, Quality of Life and Caregiver Burden in End Stage Renal Disease
Concurrent Care for Children
One group that already has a legal right to concurrent curative and hospice care is children. Section 2302 of the Affordable Care Act requires all state Medicaid plans to finance both curative treatment and hospice services simultaneously for pediatric patients.15PubMed Central. Variation in state Medicaid implementation of ACA: The case of Concurrent Care for Children For a child on dialysis who qualifies for hospice, Medicaid must cover both. This provision was a recognition that forcing families to choose between trying to save their child and accessing comfort care was cruel and unnecessary.
The existence of this pediatric rule raises an obvious question: if concurrent care works for children, why not extend the principle to adults? Advocates for kidney disease patients have pointed to the pediatric concurrent care model, along with the VA’s experience, as proof that the forced choice between dialysis and hospice is a policy artifact, not a clinical necessity. Whether Medicare will eventually adopt a similar approach for adult dialysis patients remains uncertain, but the conversation is active among nephrologists, palliative care specialists, and health policy researchers who view the current system as causing avoidable suffering.